42Stockpicking

ENOV

Enovis Corp
NYSE·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
0,8
4th %ile · 404p
P/Si
0,2
4th %ile · 356p
EV/Salesi
0,4
9th %ile · 356p
Div yieldi

Kursudvikling

Kun 75 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
75
Årsregnskaber
18
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-17 til 2026-06-03

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

ENOV vurderet 2026-06-10

Score
47.0%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

73%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

68%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

31%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

61%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

30%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

59%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
3.200
Net 90d (værdi)
70.338 USD
Købere 90d
1
Cluster
DatoPersonRolleTypeAntalVærdiKilde
15.6.2026Engert OliverChief Administrative Officer▲ KØB1.00020.920 USDsec
11.6.2026Engert OliverChief Administrative Officer▲ KØB2004.198 USDsec
10.6.2026Engert OliverChief Administrative Officer▲ KØB1.00023.000 USDsec
1.6.2026Engert OliverChief Administrative Officer▲ KØB1.00022.220 USDsec
19.5.2026Lalor Angela S· ANDET9.346sec
19.5.2026Ortiz Christine· ANDET9.346sec
19.5.2026Vinnakota Rajiv· ANDET9.346sec
19.5.2026Bodem Barbara W.· ANDET9.346sec
19.5.2026Shirley Brady· ANDET9.346sec
19.5.2026Okala Philip· ANDET9.346sec
19.5.2026Wienbar Sharon L· ANDET9.346sec
19.5.2026Kelly Liam· ANDET9.346sec
19.5.2026PERFALL A CLAYTON· ANDET9.346sec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.20260,890,81+9.9%+9.9%Beat
2025Q430.1.20260,950,84+13.1%+13.1%Beat
2025Q330.10.20250,750,65+15.6%+15.6%Beat
2025Q230.7.20250,790,72+9.9%+9.9%Beat